Latest Personal Genome Diagnostics Inc. Stories
HLI Licenses PGDx's Suite of Cancer Solutions to Expand the Company's Cancer Genomics Offering BALTIMORE and LA JOLLA, Calif., Jan.
--PlasmaSelect-R(TM) Accurately Identifies Tumor-Specific Sequence Mutations and Translocations in 63 Cancer Genes from Blood Samples-- BALTIMORE, Jan.
Recent Senior Level Hires Bring Additional Experience in Operations and R&D Management BALTIMORE, Dec. 30, 2014 /PRNewswire/ -- Personal Genome Diagnostics Inc.
--Genomic Data in Study Published in Nature Communications Suggests New Treatment Strategies for These Hard to Treat Women's Reproductive Cancers-- BALTIMORE and CAMBRIDGE, Mass., Sept.
--Study in Nature Genetics Used PGDx Exome Analysis to Identify Previously Unknown Mutation with Potential as New Drug Target for Lethal Childhood Brain Cancer-- BALTIMORE, June
--First-in-Class CLIA Assay for Detection of Tumor-Specific Gene Amplifications Using Circulating Cell-Free DNA-- BALTIMORE, April 2, 2014 /PRNewswire/ -- Personal Genome Diagnostics
--New Publication in Science Translational Medicine Confirms Utility of Cell-Free Circulating Tumor DNA (ctDNA) for Cancer Drug Development and Diagnosis-- BALTIMORE, Md., Feb.
- Withering but not falling off, as a blossom that persists on a twig after flowering.